Kiniksa Pharmaceuticals International, plc (KNSA) vs MiniMed Group, Inc. Common Stock (MMED)
A side-by-side comparison of Kiniksa Pharmaceuticals International, plc and MiniMed Group, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
KNSA
Kiniksa Pharmaceuticals International, plc
$74.09HealthcareDelayed quote: Oct 6, 2026, 10:40 AM EDT
MMED
MiniMed Group, Inc. Common Stock
$19.81HealthcareDelayed quote: Oct 6, 2026, 10:40 AM EDT
Total return — KNSA vs MMED
growth of $100 · dividends reinvested · last 1yKNSA +61.4% (+61.4%/yr)MMED +9.0% (+9.0%/yr)KNSA compounded faster over this window
KNSA MMED
KNSA vs MMED: by the numbers
- •KNSA is the larger company ($5.65B vs $5.56B market cap).
- •KNSA is profitable (9.59% net margin) while MMED runs a net loss (-10.21%).
Metrics side by side
Valuation
| Metric | KNSA | MMED |
|---|---|---|
| P/E ratio | 75.60 | N/A |
| Forward P/E | 53.20 | 29.42 |
| P/S ratio | 6.71 | 1.73 |
| P/B ratio | 8.63 | 1.54 |
| EV / EBITDA | 53.70 | 30.95 |
| FCF yield | 3.24% | N/A |
Profitability
| Metric | KNSA | MMED |
|---|---|---|
| Gross margin | 54.49% | 53.85% |
| Operating margin | 11.92% | 0.53% |
| Net margin | 9.59% | -10.21% |
| ROE | 12.33% | -9.09% |
| ROIC | 9.76% | 0.43% |
Growth (annualized)
| Metric | KNSA | MMED |
|---|---|---|
| Revenue CAGR (5Y) | 155.66% | N/A |
| Total return CAGR (5Y) | 47.48% | N/A |
Frequently asked
- Is KNSA or MMED more profitable?
- KNSA runs the higher net margin — KNSA at 9.59% versus MMED at -10.21%.
Go deeper
Dig into the metrics
Kiniksa Pharmaceuticals International P/E ratioKiniksa Pharmaceuticals International ROEMiniMed Group, Inc. Common Stock ROEKiniksa Pharmaceuticals International operating marginMiniMed Group, Inc. Common Stock operating marginKiniksa Pharmaceuticals International revenue growthMiniMed Group, Inc. Common Stock revenue growthKiniksa Pharmaceuticals International free cash flowMiniMed Group, Inc. Common Stock free cash flow
Kiniksa Pharmaceuticals International & MiniMed Group, Inc. Common Stock appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.